Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.

@article{Katayama2009SelectionOH,
  title={Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.},
  author={Yuki Katayama and Hiroko Murakami-Kuroda and Longzhu Cui and Keiichi Hiramatsu},
  journal={Antimicrobial agents and chemotherapy},
  year={2009},
  volume={53 8},
  pages={3190-6}
}
Vancomycin (VAN)-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA) isolates are considered to have emerged from VAN-susceptible S. aureus (VSSA) by spontaneous mutation during VAN exposure. We previously reported that laboratory mutant H14, obtained from VSSA strain Delta IP by exposure to imipenem (IPM), showed overexpression of the vraSR two-component system and a typical hVISA phenotype. In the present study, to elucidate the mechanism of VSSA conversion to hVISA, we… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Targeting bactoprenol-coupled cell envelope precursors

Applied Microbiology and Biotechnology • 2016
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.

Proceedings of the National Academy of Sciences of the United States of America • 2007

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2005
View 1 Excerpt

The management of infections due to drugresistant gram-positive bacteria

R. C. Moellering, Jr.
Eur. J. Clin. Microbiol. Infect. Dis • 2005
View 1 Excerpt

Similar Papers

Loading similar papers…